MINIMUM bio Employee Directory

MINIMUM bio specializes in rapid and agnostic drug target identification through its innovative Mercurious® platform, which utilizes phage-displayed cDNA libraries to discover first-in-class drug targets in oncology, immunology, and longevity. The company focuses on building extensive libraries of rapamycin analogs (rapalogs) to identify targets an... d enhance drug development processes. Their technology allows for the identification of low-abundance proteins and provides primary target data within one to two weeks, significantly reducing costs compared to traditional methods. MINIMUM bio aims to partner with organizations to unlock value in drug discovery and access previously undruggable targets.Read More